Clinical advances of nanocarrier-based cancer therapy and diagnostics.

Abstract:

INTRODUCTION:Cancer is a leading cause of death worldwide and efficient new strategies are urgently needed to combat its high mortality and morbidity statistics. Fortunately, over the years, nanotechnology has evolved as a frontrunner in the areas of imaging, diagnostics and therapy, giving the possibility of monitoring, evaluating and individualizing cancer treatments in real-time. Areas covered: Polymer-based nanocarriers have been extensively studied to maximize cancer treatment efficacy and minimize the adverse effects of standard therapeutics. Regarding diagnosis, nanomaterials like quantum dots, iron oxide nanoparticles or gold nanoparticles have been developed to provide rapid, sensitive detection of cancer and, therefore, facilitate early treatment and monitoring of the disease. Therefore, multifunctional nanosystems with both imaging and therapy functionalities bring us a step closer to delivering precision/personalized medicine in the cancer setting. Expert opinion: There are multiple barriers for these new nanosystems to enter the clinic, but it is expected that in the near future, nanocarriers, together with new 'targeted drugs', could replace our current treatments and cancer could become a nonfatal disease with good recovery rates. Joint efforts between scientists, clinicians, the pharmaceutical industry and legislative bodies are needed to bring to fruition the application of nanosystems in the clinical management of cancer.

journal_name

Expert Opin Drug Deliv

authors

Luque-Michel E,Imbuluzqueta E,Sebastián V,Blanco-Prieto MJ

doi

10.1080/17425247.2016.1205585

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

75-92

issue

1

eissn

1742-5247

issn

1744-7593

journal_volume

14

pub_type

杂志文章,评审
  • Disease guided optimization of the respiratory delivery of microparticulate formulations.

    abstract:BACKGROUND:Inhalation of microparticulate dosage forms can be effectively used in the treatment of respiratory and systemic diseases. OBJECTIVE:Disease states investigated for treatment by inhalation of microparticles were reviewed along with the drugs' pharmacological, pharmacokinetic and physical chemical properties...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.3.269

    authors: Xie Y,Zeng P,Wiedmann TS

    更新日期:2008-03-01 00:00:00

  • The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis.

    abstract::Introduction: Cisplatin has been indicated for several malignancies all over the world for many years. Increasing patient tolerance for high dose of chemotherapeutics and reducing side effects has been granted by drug encapsulated liposomal systems. There have been much efforts for improving cisplatin delivery to the ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1737672

    authors: Zahednezhad F,Zakeri-Milani P,Shahbazi Mojarrad J,Valizadeh H

    更新日期:2020-04-01 00:00:00

  • Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration.

    abstract:OBJECTIVE:The aim of this study was to improve the drug loading (DL) and stability of clarithromycin (CLA)-loaded liposomes, and reduce the irritation caused by intravenous administration of CLA. METHODS:A CLA-cholesteryl hemisuccinate (CHEMS) ion pair (CIP) was prepared by the solvent evaporation method and confirmed...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2016.1123247

    authors: Geng S,Liu X,Xu H,Cai C,Zhang Y,Yao Q,Xu H,Gou J,Yin T,Xiao W,Tang X

    更新日期:2016-01-01 00:00:00

  • Drug delivery strategies for therapy of visceral leishmaniasis.

    abstract:IMPORTANCE OF THE FIELD:Visceral leishmaniasis (VL) is the most overwhelming type of leishmaniasis associated with the poverty of developing countries and usually mortal if untreated. Most of the conventionally used dosage forms offer us the shortcomings of toxic side effects and emergence of drug resistance. Several e...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903548232

    authors: Gupta S,Pal A,Vyas SP

    更新日期:2010-03-01 00:00:00

  • The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems.

    abstract:INTRODUCTION:Nanoparticles are anticipated to overcome persistent challenges in efficient drug delivery, but the limitations associated with conventional methods of preparation are resulting in slow translation from research to clinical applications. Due to their enormous potential, microfluidic technologies have emerg...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1446936

    authors: Martins JP,Torrieri G,Santos HA

    更新日期:2018-05-01 00:00:00

  • In situ gel systems as 'smart' carriers for sustained ocular drug delivery.

    abstract:INTRODUCTION:In situ gel systems refer to a class of novel delivery vehicles, composed of natural, semisynthetic or synthetic polymers, which present the unique property of sol-gel conversion on receipt of biological stimulus. AREAS COVERED:The present review summarizes the latest developments in in situ gel technolog...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.665367

    authors: Agrawal AK,Das M,Jain S

    更新日期:2012-04-01 00:00:00

  • Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release.

    abstract:INTRODUCTION:Polymers can be designed to modify their features as a function of the level and nature of the surrounding microorganisms. Such responsive polymers can endow drug delivery systems and drug-medical device combination products with improved performance against intracellular infections and biofilms. AREAS CO...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1178719

    authors: Alvarez-Lorenzo C,Garcia-Gonzalez CA,Bucio E,Concheiro A

    更新日期:2016-08-01 00:00:00

  • Advances in non-invasive drug delivery for atherosclerotic heart disease.

    abstract:INTRODUCTION:Apart from statins, anti-platelet agents and invasive procedures, the anti-atherosclerotic medical weaponry for coronary heart disease (CHD) is scarce and only partially protects CHD patients from major adverse cardiac events. AREAS COVERED:Several novel non-invasive strategies are being developed to wide...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.999663

    authors: Maranhão RC,Tavares ER

    更新日期:2015-07-01 00:00:00

  • Properties, characteristics and applications of microbubbles for sonothrombolysis.

    abstract:INTRODUCTION:Ultrasound enhancement of thrombolysis (sonothrombolysis) is further potentiated by administration of acoustically active microbubbles, which may be developed into powerful adjuvant therapies for thrombolytic treatment of occlusive conditions such as ischaemic stroke. AREAS COVERED:The role of microbubble...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.868434

    authors: de Saint Victor M,Crake C,Coussios CC,Stride E

    更新日期:2014-02-01 00:00:00

  • Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.

    abstract:BACKGROUND:Pressurized metered-dose inhalers (pMDIs) include hydrofluoroalkane (HFA) propellant to generate a drug aerosol upon actuation and drugs can be formulated as solution or suspension. Suspended particles can cream or sediment depending on density differences between drug and propellant and shaking the pMDI is ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1767066

    authors: Chierici V,Cavalieri L,Piraino A,Paleari D,Quarta E,Sonvico F,Melani AS,Buttini F

    更新日期:2020-07-01 00:00:00

  • Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems.

    abstract:BACKGROUND:Increasing interest in digitally enhanced drug delivery tools urges both industry and academia to rethink current approaches to product usability testing. This article introduces mobile eye-tracking, generating detailed contextual data about user engagement with connected self-injection systems as a new meth...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2019.1563070

    authors: Lohmeyer Q,Schneider A,Jordi C,Lange J,Meboldt M

    更新日期:2019-02-01 00:00:00

  • Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.

    abstract::The CYPHER (Cordis, Johnson & Johnson) sirolimus-eluting stent and the TAXU (Boston Scientific) paclitaxel-eluting stent have been extensively evaluated and have been proven to be significant novel tools for the treatment of coronary artery disease. Several sirolimus derivatives have already emerged, receiving CE Mark...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.3.6.783

    authors: Vaina S,Serruys PW

    更新日期:2006-11-01 00:00:00

  • Integrin targeted drug and gene delivery.

    abstract:IMPORTANCE OF THE FIELD:Recently, there has been substantial progress in the development of integrin targeted pharmaceuticals and drug delivery systems. Integrin is an important member in the cell adhesion molecule family, which is involved in regulation of complex biological conditions, from keeping normal physiologic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903468696

    authors: Wang Z,Chui WK,Ho PC

    更新日期:2010-02-01 00:00:00

  • Application of pectin in oral drug delivery.

    abstract:INTRODUCTION:Biopolymers have been used extensively in the pharmaceutical field. Pectin, a biopolymer, has several unique properties that enable it to be used as an excipient or carrier for oral drug delivery systems. Accordingly, several investigators have identified the benefits of pectin-based delivery systems for o...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.584867

    authors: Sriamornsak P

    更新日期:2011-08-01 00:00:00

  • Photosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms.

    abstract:BACKGROUND:Photodynamic therapy (PDT) is a medical treatment in which a combination of a photosensitising drug and visible light causes destruction of selected cells. Due to the lack of true selectivity of preformed photosensitisers for neoplastic tissue and their high molecular weights, PDT of superficial skin lesions...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.7.757

    authors: Donnelly RF,McCarron PA,Morrow DI,Sibani SA,Woolfson AD

    更新日期:2008-07-01 00:00:00

  • Nanostructured hyaluronic acid-based materials for active delivery to cancer.

    abstract:IMPORTANCE OF THE FIELD:Active targeting of bioactive molecules by physicochemical association with hyaluronic acid (HA) is an attractive approach in current nanomedicine because HA is biocompatible, non-toxic and non-inflammatory. AREAS COVERED IN THIS REVIEW:This review focuses on synthesis, physicochemical characte...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425241003730399

    authors: Ossipov DA

    更新日期:2010-06-01 00:00:00

  • The importance of patient compliance with insulin pens: how can a new user-friendly pen help?

    abstract::FlexTouch® (FT) is a new prefilled insulin pen with the unique characteristic of no extendable push button at any dose setting and consequently a low activation force. Its technical features along with health care professionals' and patients' preferences in comparison to other traditionally used devices for insulin de...

    journal_title:Expert opinion on drug delivery

    pub_type: 社论

    doi:10.1517/17425247.2014.894505

    authors: Pafili K,Papanas N

    更新日期:2014-05-01 00:00:00

  • Technology-derived storage solutions for stabilizing insulin in extreme weather conditions I: the ViViCap-1 device.

    abstract:BACKGROUND:Injectable life-saving drugs should not be exposed to temperatures <4°C/39°F or >30°C/86°F. Frequently, weather conditions exceed these temperature thresholds in many countries. Insulin is to be kept at 4-8°C/~ 39-47°F until use and once opened, is supposed to be stable for up to 31 days at room temperature ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2017.1316261

    authors: Pfützner A,Pesach G,Nagar R

    更新日期:2017-06-01 00:00:00

  • New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.

    abstract::dl-Methylphenidate (MPH) remains the most widely used pharmacological agent in the treatment of attention-deficit/hyperactivity disorder (ADHD). The predominantly dopaminergic mechanism of the psychostimulant actions has become more clearly defined. Neuroimaging and genetic studies are revealing the underlying neuropa...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.1.121

    authors: Patrick KS,González MA,Straughn AB,Markowitz JS

    更新日期:2005-01-01 00:00:00

  • Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them.

    abstract::Introduction: Peritoneal metastases of cancer remain a major cause of an adverse outcome and death following surgical treatment of malignancies that occur within the abdomen and pelvis. The administration of a chemotherapy solution directly into the peritoneal space has been used to improve the survival in this group ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1693997

    authors: Sugarbaker PH

    更新日期:2019-12-01 00:00:00

  • High-density lipoproteins for the systemic delivery of short interfering RNA.

    abstract:INTRODUCTION:RNA interference (RNAi) is a powerful mechanism for gene silencing with the potential to greatly impact the development of new therapies for many human diseases. Short interfering RNAs (siRNAs) may be the ideal molecules for therapeutic RNAi. However, therapeutic siRNAs face significant challenges that mus...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.866089

    authors: McMahon KM,Thaxton CS

    更新日期:2014-02-01 00:00:00

  • Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.

    abstract:INTRODUCTION:Recent developments in ultrasound imaging and ultrasound contrast agents (UCAs) improved diagnostic confidence in echography and set into motion their combined use as a tool for drug delivery and therapeutic monitoring. Non-invasive, precise and targeted delivery of drug molecules to pathological tissues b...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1266328

    authors: Sennoga CA,Kanbar E,Auboire L,Dujardin PA,Fouan D,Escoffre JM,Bouakaz A

    更新日期:2017-09-01 00:00:00

  • Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.

    abstract::Introduction: Current therapies of neurodegenerative or neurometabolic diseases are, to a large extent, hampered by the inability of drugs to cross the blood-brain barrier (BBB). This very tight barrier severely restricts the entrance of molecules from the blood into the brain, especially macromolecular substances (i....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1698544

    authors: Tosi G,Duskey JT,Kreuter J

    更新日期:2020-01-01 00:00:00

  • Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.

    abstract:INTRODUCTION:A major problem with conventional antitumor therapeutics is nonselective delivery of cytotoxic drugs to normal vital organs and tissues but little delivery to tumor tissues. AREAS COVERED:Here, the authors describe the tumor selective delivery of antitumor drugs by taking advantage of nano-sized drugs and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.955011

    authors: Nakamura H,Fang J,Maeda H

    更新日期:2015-01-01 00:00:00

  • Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.

    abstract::Objective: Conventional chloramphenicol (CHL) eye drops are widely used anti-infection formulations for acute bacterial conjunctivitis. However, the therapeutic effects are limited by insufficient concentration in the conjunctival sac. Hence, the objective of this study is to formulate and develop novel CHL eye drops ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2019.1609447

    authors: Xu Y,Zhang C,Zhu X,Wang X,Wang H,Hu G,Fu Q,He Z

    更新日期:2019-06-01 00:00:00

  • Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.

    abstract:INTRODUCTION:Pressurized metered dose inhalers (pMDIs) are evolving to be a very effective drug delivery option in patients with airway diseases. They offer comparable lung deposition and reduced oropharyngeal deposition similar with the dry powder inhalers. As recommended by the Global Initiative for Asthma guidelines...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.987661

    authors: Mehta N,Aggarwal B,Gogtay J,Abdool-Gaffar S

    更新日期:2015-06-01 00:00:00

  • Liposomes for targeted delivery of antithrombotic drugs.

    abstract:BACKGROUND:Targeted delivery of antithrombotic (thrombolytic) drugs is expected to increase their efficacy and decrease side effects, especially in the case of thrombolytic enzymes. Liposomes, phospholipid nanosized bubbles with a bilayered membrane structure, have drawn a lot of interest as pharmaceutical carriers for...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240802497457

    authors: Elbayoumi TA,Torchilin VP

    更新日期:2008-11-01 00:00:00

  • Recent updates in utilizing prodrugs in drug delivery (2013-2015).

    abstract:INTRODUCTION:Utilizing the prodrug approach as a method to overcome various pharmaceutical and pharmacokinetic barriers to drug delivery is significantly accelerating and achieving successes. In contrast to the older traditional prodrugs which suffer from decreased bioavailability and a high profile of side effects, du...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1142527

    authors: Amly W,Karaman R

    更新日期:2016-01-01 00:00:00

  • A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol.

    abstract::Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electromechanical self-injection device (e-Device) developed for certolizumab pegol (CZP) administration, aims to overcome some barriers to increase adherence. This study evaluates patient experience of the e-Device and its tra...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1736552

    authors: Pouls BPH,Kristensen LE,Petersson M,van den Bemt BJF,Ballerini L,Bruggraber R,Karlen H,Mountian I,van Bracht E,Wiegratz S,Jørgensen TS

    更新日期:2020-05-01 00:00:00

  • New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.

    abstract:INTRODUCTION:Inflammatory bowel disease (IBD) is an exceptional scenario with regard to drug targeting, as oral administration has the potential to deliver the drug directly to the site(s) of action. Consequently, retention of the drug within the intestinal lumen and tissue, rather than systemic absorption, is frequent...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.800480

    authors: Wolk O,Epstein S,Ioffe-Dahan V,Ben-Shabat S,Dahan A

    更新日期:2013-09-01 00:00:00